HIV Drug Wholesalers' Attys Get $75M In Gilead Antitrust Case

By Bonnie Eslinger · January 22, 2024, 6:47 PM EST

A California federal judge has given final approval to Gilead Sciences' $247 million settlement with direct purchasers of HIV medications, including an award of $75 million for attorney fees, ending claims...

To view the full article, register now.